Report cover image

NA Psychedelic Drugs Market - Industry Trends and Forecast to 2029

Publisher Data Bridge Market Research
Published May 01, 2022
Length 173 Pages
SKU # DAABD17330403

Description

NA Psychedelic Drugs Market - Industry Trends and Forecast to 2029

North America psychedelic drugs market is projected to register a substantial CAGR of 13.4% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation:
North America Global Psychedelic Drugs Market, By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)

Country (U.S., Canada, Mexico and Rest of North America) Industry Trends and Forecast to 2029

Some of the major factors affecting the growth of North America psychedelic drugs market are:
• Due to increasing prevalence of depression and mental disorder
• Growing Acceptance Of Psychedelic Drugs For Treating Depression

Market Players

The key market players for North America psychedelic drugs market are listed below:
• Jazz Pharmaceuticals, Inc.
• Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.)
• Hikma Pharmaceuticals PLC
• COMPASS
• Pfizer Inc.
• Avadel
• Cybin Corp.
• Entheon Biomedical Corp
• PharmaTher Holdings Ltd.
• NRx Pharmaceuticals, Inc.
• usonainstitute.org

Table of Contents

173 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America Psychedelic Drugs Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market End User Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insight
4.1 Pipeline Analysis
4.2 Pestel Analysis
4.3 Porter's Five Forces Model
5 Regulatory Framework: North America Psychedelic Drugs Market
5.1 Regulatory Scenario In The U.S.
5.2 Regulatory Scenario In The U.K.
5.3 Regulatory Scenario In India
5.4 Regulatory Scenario In Uae
5.5 Regulatory Scenario In Africa
5.6 Regulatory Scenario In Brazil
6 Market Overview
6.1 Drivers
6.1.1 Growing Acceptance Of Psychedelic Drugs To Treat Depression
6.1.2 Increasing Prevalence Of Depression And Mental Disorders
6.1.3 Rising Awareness Toward Mental Health
6.1.4 Ongoing Clinical Trials
6.1.5 Rise In Product Approvals
6.2 Restraints
6.2.1 Stringent Regulations For Psychedelic Drugs
6.2.2 High Cost Of Psychedelic Drugs
6.2.3 Patent Expiry Of Psychedelic Drugs
6.3 Opportunities
6.3.1 Increasing R&D Activities In Psychedelic Drugs
6.3.2 Breakthrough Therapy Designation By Regulatory Authority
6.3.3 Upcoming Rehabilitation Centers
6.3.4 Availability Of Certified Healthcare Professionals
6.4 Challenges
6.4.1 Side Effects Associated With Psychedelic Drugs
6.4.2 Rise In Illegal Alternatives
6.4.3 Availability Of Other Treatment Options
7 Covid-19 Impact On The North America Psychedelic Drugs Market
7.1 Impact On Price
7.2 Impact On Demand
7.3 Impact On Supply Chain
7.4 Strategic Decisions For Manufacturers
7.5 Conclusion
8 North America Psychedelic Drugs Market, By Type
8.1 Overview
8.2 Empathogens
8.3 Dissociatives
8.4 Others
9 North America Psychedelic Drugs Market, By Source
9.1 Overview
9.2 Synthetic
9.3 Natural
10 North America Psychedelic Drugs Market, By Drugs
10.1 Overview
10.2 Gamma-hydroxybutyric Acid
10.3 Ketamine
10.4 Psilocybin
10.5 Others
11 North America Psychedelic Drugs Market, By Application
11.1 Overview
11.2 Narcolepsy
11.3 Treatment Resistant Depression
11.4 Major Depressive Disorder
11.5 Opiate Addiction
11.6 Post-traumatic Stress Disorder
11.7 Others
12 North America Psychedelic Drugs Market, By Route Of Administration
12.1 Overview
12.2 Oral
12.3 Inhalation
12.4 Injectable
13 North America Psychedelic Drugs Market, By End User
13.1 Overview
13.2 Hospitals
13.3 Specialty Clinics
13.4 Homecare
13.5 Others
14 North America Psychedelic Drugs Market, By Distribution Channel
14.1 Overview
14.2 Hospitals Pharmacy
14.3 Retail Pharmacy
14.4 Online Pharmacy
15 North America Psychedelic Drugs Market, By Region
15.1 North America
15.1.1 U.S.
15.1.2 Canada
15.1.3 Mexico
16 North America Psychedelic Drugs Market: Company Landscape
16.1 Company Share Analysis: North America
17 Swot Analysis
18 Company Profile
18.1 Jazz Pharmaceuticals, Inc.
18.1.1 Company Snapshot
18.1.2 Revenue Analysis
18.1.3 Company Share Analysis
18.1.4 Product Portfolio
18.1.5 Recent Developments
18.2 Pfizer Inc.
18.2.1 Company Snapshot
18.2.2 Revenue Analysis
18.2.3 Company Share Analysis
18.2.4 Product Portfolio
18.2.5 Recent Developments
18.3 F. Hoffmann- La Roche Ltd
18.3.1 Company Snapshot
18.3.2 Revenue Analysis
18.3.3 Company Share Analysis
18.3.4 Product Portfolio
18.3.5 Recent Development
18.4 Janssen North America Services, Llc (A Subsidiary Of Johnson & Johnson Services, Inc.)
18.4.1 Company Snapshot
18.4.2 Company Share Analysis
18.4.3 Product Portfolio
18.4.4 Recent Development
18.5 Avadel
18.5.1 Company Snapshot
18.5.2 Product Portfolio
18.5.3 Recent Development
18.6 Celon Pharma Sa
18.6.1 Company Snapshot
18.6.2 Product Portfolio
18.6.3 Recent Development
18.7 Compass
18.7.1 Company Snapshot
18.7.2 Product Portfolio
18.7.3 Recent Developments
18.8 Cybin Corp.
18.8.1 Company Snapshot
18.8.2 Product Portfolio
18.8.3 Recent Developments
18.9 Entheon Biomedical Corp
18.9.1 Company Snapshot
18.9.2 Product Portfolio
18.9.3 Recent Development
18.10 Gh Research
18.10.1 Company Snapshot
18.10.2 Product Portfolio
18.10.3 Recent Development
18.11 Hikma Pharmaceuticals Plc
18.11.1 Company Snapshot
18.11.2 Revenue Analysis
18.11.3 Product Portfolio
18.11.4 Recent Developments
18.12 Nrx Pharmaceuticals, Inc.
18.12.1 Company Snapshot
18.12.2 Product Portfolio
18.12.3 Recent Development
18.13 Pharmather Holdings Ltd.
18.13.1 Company Snapshot
18.13.2 Product Portfolio
18.13.3 Recent Development
18.14 Verrian
18.14.1 Company Snapshot
18.14.2 Product Portfolio
18.14.3 Recent Development
18.15 Usonainstitute.Org
18.15.1 Company Snapshot
18.15.2 Product Portfolio
18.15.3 Recent Development
19 Questionnaire
20 Related Reports
List Of Tables
Table 1 North America Psychedelic Drugs Market, Pipeline Analysis
Table 2 Psychedelics Research Studies, In Europe
Table 3 Mental Illness In The U.S. Adults, In 2020
Table 4 Mental Disorders, In The U.S. Adults, In 2020
Table 5 Drug Development Pathway For Fda Approval Of New Medications
Table 6 The 1971 Un Convention On Psychotropic Substances
Table 7 Magic Mushrooms Prices For Researchers, In The U.S.
Table 8 Cost Of Psychedelic Drugs
Table 9 Psychedelic Drugs R&D Activities
Table 10 North America Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million)
Table 11 North America Empathogens In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 12 North America Dissociatives In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 13 North America Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 14 North America Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million)
Table 15 North America Synthetic In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 16 North America Natural In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 17 North America Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million)
Table 18 North America Gamma-hydroxybutyric Acid In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 19 North America Ketamine In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 20 North America Psilocybin In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 21 North America Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 22 North America Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million)
Table 23 North America Narcolepsy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 24 North America Treatment Resistant Depression In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 25 North America Major Depressive Disorder In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 26 North America Opiate Addiction In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 27 North America Post-traumatic Stress Disorder In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 28 North America Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 29 North America Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million)
Table 30 North America Oral In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 31 North America Inhalation In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 32 North America Injectable In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 33 North America Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million)
Table 34 North America Hospitals In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 35 North America Specialty Clinics In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 36 North America Homecare In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 37 North America Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 38 North America Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 39 North America Hospitals Pharmacy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 40 North America Retail Pharmacy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 41 North America Online Pharmacy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 42 North America Psychedelic Drugs Market, By Country, 2020-2029 (Usd Million)
Table 43 North America Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million)
Table 44 North America Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million)
Table 45 North America Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million)
Table 46 North America Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million)
Table 47 North America Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million)
Table 48 North America Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million)
Table 49 North America Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 50 U.S. Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million)
Table 51 U.S. Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million)
Table 52 U.S. Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million)
Table 53 U.S. Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million)
Table 54 U.S. Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million)
Table 55 U.S. Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million)
Table 56 U.S. Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 57 Canada Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million)
Table 58 Canada Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million)
Table 59 Canada Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million)
Table 60 Canada Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million)
Table 61 Canada Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million)
Table 62 Canada Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million)
Table 63 Canada Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 64 Mexico Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million)
Table 65 Mexico Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million)
Table 66 Mexico Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million)
Table 67 Mexico Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million)
Table 68 Mexico Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million)
Table 69 Mexico Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million)
Table 70 Mexico Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million)
List Of Figures
Figure 1 North America Psychedelic Drugs Market: Segmentation
Figure 2 North America Psychedelic Drugs Market : Data Triangulation
Figure 3 North America Psychedelic Drugs Market: Droc Analysis
Figure 4 North America Psychedelic Drugs Market: North America Vs Regional Market Analysis
Figure 5 North America Psychedelic Drugs Market: Company Research Analysis
Figure 6 North America Psychedelic Drugs Market: Multivariate Modelling
Figure 7 North America Psychedelic Drugs Market: Interview Demographics
Figure 8 North America Psychedelic Drugs Market: Dbmr Market Position Grid
Figure 9 North America Psychedelic Drugs Market: End User Coverage Grid
Figure 10 North America Psychedelic Drugs Market: Vendor Share Analysis
Figure 11 North America Psychedelic Drugs Market: Segmentation
Figure 12 North America Is Expected To Dominate The North America Psychedelic Drugs Market Growing With The Highest Cagr In The Forecast Period Of 2022 To 2029
Figure 13 Rising Awareness Towards Merantal Health Driving The North America Psychedelic Drugs Market In The Forecast Period Of 2022 To 2029
Figure 14 Empathogens Segment Is Expected To Account For The Largest Share Of The North America Psychedelic Drugs Market In 2022 & 2029
Figure 15 Drivers, Restraints, Opportunities, And Challenges Of The North America Psychedelic Drugs Market
Figure 16 Mental Illness Among The U.S. Adults, In 2020, (In %), By Demographic Groups
Figure 17 Mental Illness Treatment Rates Among The U.S. Adults, In 2020, (In %), By Demographic Groups
Figure 18 Mental Illness Treatment Rates Among The U.S. Adults, In 2020, (In %), By Gender
Figure 19 North America Psychedelic Drugs Market: By Type, 2021
Figure 20 North America Psychedelic Drugs Market: By Type, 2022-2029 (Usd Million)
Figure 21 North America Psychedelic Drugs Market: By Type, Cagr (2022-2029)
Figure 22 North America Psychedelic Drugs Market: By Type, Lifeline Curve
Figure 23 North America Psychedelic Drugs Market: By Source, 2021
Figure 24 North America Psychedelic Drugs Market: By Source, 2022-2029 (Usd Million)
Figure 25 North America Psychedelic Drugs Market: By Source, Cagr (2022-2029)
Figure 26 North America Psychedelic Drugs Market: By Source, Lifeline Curve
Figure 27 North America Psychedelic Drugs Market: By Drugs, 2021
Figure 28 North America Psychedelic Drugs Market: By Drugs, 2022-2029 (Usd Million)
Figure 29 North America Psychedelic Drugs Market: By Drugs, Cagr (2022-2029)
Figure 30 North America Psychedelic Drugs Market: By Drugs, Lifeline Curve
Figure 31 North America Psychedelic Drugs Market: By Application, 2021
Figure 32 North America Psychedelic Drugs Market: By Application, 2022-2029 (Usd Million)
Figure 33 North America Psychedelic Drugs Market: By Application, Cagr (2022-2029)
Figure 34 North America Psychedelic Drugs Market: By Application, Lifeline Curve
Figure 35 North America Psychedelic Drugs Market: By Route Of Administration, 2021
Figure 36 North America Psychedelic Drugs Market: By Route Of Administration, 2022-2029 (Usd Million)
Figure 37 North America Psychedelic Drugs Market: By Route Of Administration, Cagr (2022-2029)
Figure 38 North America Psychedelic Drugs Market: By Route Of Administration, Lifeline Curve
Figure 39 North America Psychedelic Drugs Market: By End User, 2021
Figure 40 North America Psychedelic Drugs Market: By End User, 2022-2029 (Usd Million)
Figure 41 North America Psychedelic Drugs Market: By End User, Cagr (2022-2029)
Figure 42 North America Psychedelic Drugs Market: By End User, Lifeline Curve
Figure 43 North America Psychedelic Drugs Market: By Distribution Channel, 2021
Figure 44 North America Psychedelic Drugs Market: By Distribution Channel, 2022-2029 (Usd Million)
Figure 45 North America Psychedelic Drugs Market: By Distribution Channel, Cagr (2022-2029)
Figure 46 North America Psychedelic Drugs Market: By Distribution Channel, Lifeline Curve
Figure 47 North America Psychedelic Drugs Market: Snapshot (2021)
Figure 48 North America Psychedelic Drugs Market: By Country (2021)
Figure 49 North America Psychedelic Drugs Market: By Country (2022 & 2029)
Figure 50 North America Psychedelic Drugs Market: By Country (2021 & 2029)
Figure 51 North America Psychedelic Drugs Market: By Type (2022-2029)
Figure 52 North America Psychedelic Drugs Market: Company Share 2021 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us